1. Serum tryptase: an indicator of anaphylaxis following fluorescein angiography.
- Author
-
Butrus SI, Negvesky GJ, Rivera-Velazques PM, and Schwartz LB
- Subjects
- Anaphylaxis chemically induced, Anaphylaxis enzymology, Biomarkers blood, Chymases, Contrast Media administration & dosage, Female, Fluorescein administration & dosage, Fundus Oculi, Humans, Injections, Intravenous, Mast Cells enzymology, Middle Aged, Radioimmunoassay, Tryptases, Anaphylaxis diagnosis, Contrast Media adverse effects, Fluorescein adverse effects, Fluorescein Angiography adverse effects, Serine Endopeptidases blood
- Abstract
Background: Anaphylaxis is a potentially fatal complication of fluorescein angiography. It is diagnosed by clinical signs. Serum beta-tryptase serves as a specific indicator of mast cell activation and of anaphylactic shock that can be detected by radioimmunoassay., Method: This is a report on a 48-year-old woman who developed anaphylaxis during fluorescein angiography. This study investigates the role of beta-tryptase in anaphylactic shock resulting from intravenous fluorescein angiogram., Results: A serum sample of beta-tryptase collected at the time of an adverse reaction to fluorescein angiography was determined by radioimmunassay to be elevated above 20 ng/ml (normal level <1 ng/ml). This indicates massive mast cell activation and anaphylactic shock., Conclusion: This case is the first in which elevated levels of beta-tryptase in serum indicated that the systemic adverse reaction to fluorescein was mast cell dependent. Additionally, beta-tryptase levels can be assayed to detect anaphylactic reactions several hours after a precipitating event.
- Published
- 1999
- Full Text
- View/download PDF